RPS3P7

Across TCGA pan-cancer cohorts, RPS3P7 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated RPS3P7 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher RPS3P7 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPS3P7 expression acts as an unfavorable survival marker, although some lineages such as COAD and GBM show a favorable association.

ACC, KIRC, and COAD are the cancer types where RPS3P7 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Quartile	All	0.112	0.518	.001	51	view →
KIRC	DFS	Median	All	0.538	0.707	.008	24	view →
COAD	DFS	Tertile	All	0.853	0.744	.012	22	view →
GBM	OS	Tertile	All	0.340	0.184	.008	16	view →
OV	OS	Quartile	II,III,IV	0.242	0.393	.031	16	view →
LAML	DFS	Median	All	0.584	0.310	.004	12	view →
LUAD	DFS	Tertile	III,IV	0.402	0.727	.008	12	view →
THYM	DFS	Tertile	II,III,IV	0.572	0.916	.015	9	view →
LUSC	DFS	Median	All	0.429	0.309	.016	9	view →
MESO	DFS	Tertile	All	0.285	0.444	.034	6	view →
LGG	OS	Quartile	All	0.633	0.363	.019	6	view →
ESCA	OS	Median	All	0.426	0.615	.024	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

RPS3P7–ACC (DFS)

Open the ACC breakdown →